Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | -1.98% | 0.00% | +29.45% |
05-15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
05-14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.45% | 41.05M | |
+47.14% | 58.71B | |
-3.53% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.76% | 26.55B | |
-22.37% | 18.98B | |
+1.46% | 12.51B | |
+24.54% | 12.08B | |
+21.72% | 11.94B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., 2022 Earnings Call, Mar 30, 2023